Machine learning predicts side effects from chemotherapy

In collaboration with Rigshospitalet, researchers from DTU Health Technology have developed a machine learning model that can predict chemotherapy-associated nephrotoxicity, a particularly significant side effect in patients treated with cisplatin.

Photo
The scientists at DTU Health Tech use AI to combine clinical files and genetics for predicting patient outcome
Source: Technical University of Denmark

Testicular cancer is the most common cancer in young men. The number of new cases is increasing worldwide. There is a relatively high survival rate, with 95% surviving after 10 years - if detected in time and treated properly. However, the standard chemotherapy includes cisplatin, which has a wide range of long-term side effects, one of which can be nephrotoxicity.

“In testicular cancer patients, cisplatin-based chemotherapy is essential to ensure a high cure rate. Unfortunately, treatment can cause side effects, including renal impairment. However, we are not able to pinpoint who ends up having side effects and who does not,” says Jakob Lauritsen from Rigshospitalet.

Patient data is key to knowledge

The researchers therefore asked the question: How far can we go in predicting nephrotoxicity risk in these patients using machine learning? First, it required some patient data. "Using a cohort of testicular-cancer patients from Denmark– in collaboration with Rigshospitalet, we developed a machine learning predictive model to tackle this problem" says Sara Garcia, a researcher at DTU Health Technology, who, together with Jakob Lauritsen, are the first authors of an article published recently in JNCI Cancer Spectrum.

The high-quality of Danish patient records allowed the identification of key patients, and a technology partnership between DMAC and YouDoBio facilitated DNA collection from patients at their homes using postal delivered saliva kits. The project, originally funded by the Danish Cancer Society, saw the development of several analyses strategies of genomics and patient data, bringing forward the promise of artificial intelligence for integration of diverse data streams.

Best predictions for low-risk patients

A risk score for an individual to develop nephrotoxicity during chemotherapy was generated, and key genes likely at play were proposed. Patients were classified into high, low, and intermediate risk. For the high-risk, the model was able to correctly predict 67% of affected patients, while for the low-risk, the model correctly predicted 92% of the patients that did not develop nephrotoxicity.

“Understanding how and where AI technologies can be applied in clinical care, is increasingly important also in the future of responsible AI. Despite patient data complexity, the high quality of Danish registries and clinical research make it a great environment for exploring new data methodologies” says Ramneek Gupta. “Being able to predict late side-effects will ultimately give us the opportunity for preventive action and improved quality of life” adds Gedske Daugaard, who is joint senior author with Ramneek Gupta.

Subscribe to our newsletter

Related articles

AI predicts effectiveness of immunotherapy

AI predicts effectiveness of immunotherapy

Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.

Endoscopic robotic system used for treating cancer

Endoscopic robotic system used for treating cancer

Researchers have developed an robotic system to enhance the safety and efficacy of endoscopic submucosal dissection (ESD) for the treatment of gastrointestinal cancer.

3D printed hydrogels to be used in cancer immunotherapy

3D printed hydrogels to be used in cancer immunotherapy

The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo.

AI predicts breast cancer risk factors

AI predicts breast cancer risk factors

Researchers report innovative use of machine learning to help understand the interplay of genetic and other breast cancer risk factors.

Melanoma: patch may be a treatment option

Melanoma: patch may be a treatment option

Scientists at Purdue University have developed a skin patch that can deliver chemotherapy into melanoma tumors in an effective and painless way.

Machine learning enhances brain tumour diagnosis

Machine learning enhances brain tumour diagnosis

A new AI approach classifies a common type of brain tumour into low or high grades with almost 98% accuracy, researchers report.

Lung cancer: AI could predict risk of recurrence

Lung cancer: AI could predict risk of recurrence

Computer scientists working with pathologists have trained an AI tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.

AI in healthcare – hype, hope and reality

AI in healthcare – hype, hope and reality

Currently, we are too focused on the topic of AI. In order, however, to leverage AI technology several challenges have to be mastered and a proper framework has to be established.

App detects side effect of breast cancer treatment

App detects side effect of breast cancer treatment

Commercially available app-based technology now makes early detection of lymphedema easier, allowing for proactive treatment.

Popular articles